Tamsulosin hydrochloride and Zepzelca drug interactions - a phase IV clinical study of FDA data
Summary:
We study 18,817 people who take Tamsulosin hydrochloride (tamsulosin hydrochloride) and Zepzelca (lurbinectedin). There is no drug interaction reported.
The study analyzes what interactions people have when they take Tamsulosin hydrochloride and Zepzelca. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Tamsulosin hydrochloride?
Tamsulosin hydrochloride has active ingredients of tamsulosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 18,329 Tamsulosin hydrochloride users. Check the latest studies of Tamsulosin hydrochloride.
What is Zepzelca?
Zepzelca has active ingredients of lurbinectedin. eHealthMe is studying from 488 Zepzelca users. Check the latest studies of Zepzelca.
No report is found.
Do you take Tamsulosin hydrochloride and Zepzelca?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Tamsulosin hydrochloride (18,329 reports)
- Zepzelca (488 reports)
How the study uses the data?
The study uses data from the FDA. It is based on tamsulosin hydrochloride and lurbinectedin (the active ingredients of Tamsulosin hydrochloride and Zepzelca, respectively), and Tamsulosin hydrochloride and Zepzelca (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Proair Hfa cause Hallucination, Auditory? - 6 seconds ago
- Could Rufinamide cause Maternal Exposure During Pregnancy? - 9 seconds ago
- Proair Hfa and Frequent Headaches for Women aged 60+ - 23 seconds ago
- Could Hydramine cause Belching? - 23 seconds ago
- Proair Hfa and Headaches for Women aged 60+ - 23 seconds ago
- Proair Hfa and Pain - Head for Women aged 60+ - 23 seconds ago
- Proair Hfa and Headache for Women aged 60+ - 24 seconds ago
- White Blood Cell Count Decreased and drugs of ingredients of lomustine - 34 seconds ago
- Omeprazole and Fibromyalgia for Men aged 50-59 - 36 seconds ago
- Omeprazole and Fibromyalgia Syndrome for Men aged 50-59 - 37 seconds ago